Advertise
NEWSLETTER
Alterity Therapeutics recei...
Aspen’s autologous ce...
Voyager IV gene therapies f...
Annovis publishes Phase 2/3...
FDA clears Denali biologic ...
Alterity Therapeutics recei...
Aspen’s autologous ce...
Voyager IV gene therapies f...
Annovis publishes Phase 2/3...
FDA clears Denali biologic ...
Wellness
Menopause- Time to test and take charge

Menopause: Time to test and take charge

Juvenesence's Greg Bailey on transformative scientific opportunities, immuno-resilience and modifying aging.

Juvenescence (1): from strength to strength in R&D and investment firepower

New era for urban wellness at Life Time Prudential Center

Opening of 60,000 sq ft club in Back Bay brings luxury wellness and longevity lifestyle into

A year in Longevity: different perspectives

A year in Longevity: science perspectives

UK start-up Cera, a technology-enabled home care provider, is one of Europe’s fastest-growing businesses with $120m in revenue.

Healthtech start-up reaches $120m revenue in under four years

Longevity investing: A UBS Investor Watch survey shows that investors would sacrifice wealth for an extra ten years of healthy life.

Would you invest $1000 per week to live longer?

Tina Woods: Prevention is vital for Longevity

Wearable firm switches focus to enterprise

Healthspan wearables and subscription services are hot!

Jinfiniti, NetraMark and Scarlette Lillie will explore the role psilocybin can play for age-related diseases.

Jinfiniti’s Startup Showcase success drives collaboration

Proposed budget cut: reduced Longevity for EU citizens?

Longevity 1.0 – new book seeks to define Longevity

Primetime Partners get ready for Longevity primetime

Lorraine Morley from Allia

AgeTech investment: “there is everything to play for”

Credit: wayhomestudio/Freepik

Targeting multiple Longevity biomarkers in a single panel

Juvenescence (2): “It’s all about prevention, and that’s incredibly disruptive”

Longevity opportunities in the post-Covid world

Sun Genomics raises $8.5m to drive market share

Real-time tracking of 400+ Longevity biomarkers

AI

AI fast-tracks human longevity extension

Biosense

Going deeper on ketone analysis for longevity

Longevity-Labs

Proving the longevity potential of spermidine

Mayo Clinic

Clearance of senescent cells for improved cognition

Longevity Escape Velocity within 10 years?

Predicting longevity using polygenic risk scores

Alex Zhavoronkov is pushing for us to examine how and when to classifying aging and how it should be implemented to overcome "inherent challenges"

Classifying aging as a disease – it’s all about the ‘how’

House of Lords report highlights that Government continues to fail to meet the challenges and realise the opportunities of aging.

Committee blasts UK Government approach to aging

We spoke recently with GlycanAge a British-Croatian start-up focused on analysing glycosylation patterns to measure biological age

Start-up claims first commercial glycan-based age test

Longevity supplement Mitocholine addresses “brain energy gap” to counteract development of metabolic syndrome and impede onset of dementia.

New Longevity supplement targets cognitive decline

Supplementing your Longevity knowledge

NOVOS Core aims to get to the heart of Longevity therapy with its new 'antiaging' multivitamin supplement.

NOVOS launches new anti-aging supplement

InsideTracker shows users what's going on inside their bodies, and provides personalized health tracking for longer life.

InsideTracker: personalised potential for a longer life

Using optogenetics on gut microbes can promote Longevity.

Gut health shines a light on Longevity

Oxford University targets arterial stiffening earlier in a person’s lifespan for age-related cognitive benefit and dementia delay.

Study linking heart health to brain health could delay dementia

Although age-related cognitive decline is commonly associated with aging, superagers retain exceptional memory performance.

Rise of the superagers – sharp minds and youthful cognition

A year in Longevity: progress perspectives

Longevity Center plans significant expansion of personalized health clinics that aim to prove the potential of Longevity interventions.

More growth in Longevity clinical business activity

Cerascreen expands from consumer biomarker testing into clinical trial recruitment and discovery of longevity compounds.

Longevity biomarker firm to align CROs, pharma and consumers

Nina Skorytchenko

Targeting inflammaging through glycomics

Progress in osteoporosis therapy as available supplement could be effective treatment to treat – or even prevent – damaging bone loss.

AKG shown to prevent age-related bone loss

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form